Browsing by Author "Ambs, S."

Now showing items 1-3 of 3

    • An immune-inflammation gene expression signature in prostate tumors of smokers 

      Prueitt, R. L.; Wallace, T. A.; Glynn, S. A.; Yi, M.; Tang, W.; Luo, J.; Dorsey, T. H.; Stagliano, K. E.; Gillespie, J. W.; Hudson, R. S.; Terunuma, A.; Shoe, J. L.; Haines, D. C.; Yfantis, H. G.; Han, M.; Martin, D. N.; Jordan, S. V.; Borin, J. F.; Naslund, M. J.; Alexander, R. B.; Stephens, R. M.; Loffredo, C. A.; Lee, D. H.; Putluri, N.; Sreekumar, A.; Hurwitz, A. A.; Ambs, S. (American Association for Cancer Research (AACR), 2015-12-30)
      Smokers develop metastatic prostate cancer more frequently than nonsmokers, suggesting that a tobacco-derived factor is driving metastatic progression. To identify smoking-induced alterations in human prostate cancer, we ...

    • Molecular pathways: toll-like receptors in the tumor microenvironment--poor prognosis or new therapeutic opportunity 

      Ridnour, L. A.; Cheng, R. Y. S.; Switzer, C. H.; Heinecke, J. L.; Ambs, S.; Glynn, S.; Young, H. A.; Trinchieri, G.; Wink, D. A. (American Association for Cancer Research (AACR), 2012-12-27)

    • Tumor microenvironment-based feed-forward regulation of nos2 in breast cancer progression 

      Heinecke, J. L.; Ridnour, L. A.; Cheng, R. Y. S.; Switzer, C. H.; Lizardo, M. M.; Khanna, C.; Glynn, S. A.; Hussain, S. P.; Young, H. A.; Ambs, S.; Wink, D. A. (Proceedings of the National Academy of Sciences, 2014-04-14)
      Inflammation is widely recognized as an inducer of cancer progression. The inflammation-associated enzyme, inducible nitric oxide synthase (NOS2), has emerged as a candidate oncogene in estrogen receptor (ER)-negative ...